Showing 1761-1770 of 21419 results for "".
- Systemic Inflammation and Hematologic Risk: Unraveling Bone Marrow Remodelinghttps://reachmd.com/news/systemic-inflammation-and-hematologic-risk-unraveling-bone-marrow-remodeling/2484530/European Molecular Biology Laboratory (EMBL) data link chronic systemic inflammation to bone marrow remodeli
- Study: Itch and Rash Severity Linked to Biologic Use in Eczemahttps://reachmd.com/news/itch-and-rash-severity-linked-to-biologic-use-in-eczema-paper/2484499/Data from a recent pre-proof in the Journal of the American Academy of Dermatology highlights that both itch and lesion severity independently predict biologic treatment initiation in patients with moderate-to-severe atopic de
- Revolutionizing Vaccine Strategies: Insights from Gut Mucosal Immunityhttps://reachmd.com/news/revolutionizing-vaccine-strategies-insights-from-gut-mucosal-immunity/2484504/A University of Toronto study found that gut immune cells can use an atypic
- New Insights into Uterine Contraction Mechanics: Implications for Labor Managementhttps://reachmd.com/news/new-insights-into-uterine-contraction-mechanics-implications-for-labor-management/2484492/A recent preclinical study suggests that stretch- and pressure-sensitive molecular sensors influence the timing and strength of uterine contractions.
- APPLAUSE-IgAN: Landmark Phase III Results for Iptacopanhttps://reachmd.com/news/applause-igan-landmark-phase-iii-results-for-iptacopan/2484489/Novartis reported that the Phase III APPLAUSE-Ig
- Assessing the Impact of Ablation Plus Immunotherapy in Advanced NSCLC: Insights from the BOOSTER Phase 2 Trialhttps://reachmd.com/news/assessing-the-impact-of-ablation-plus-immunotherapy-in-advanced-nsclc-insights-from-the-booster-phase-2-trial/2484459/In the BOOSTER trial, adding local tumor ablation to ongoing anti-PD-1/L1 therapy markedly extended progression-free survival in advanced NSCLC with oligo-residual disease. The randomized phase 2 trial demonstrates an immediately actionable approach to prolong diseas
- The Impact of Climate Change on Infectious Disease Spread: Challenges and Responseshttps://reachmd.com/news/the-impact-of-climate-change-on-infectious-disease-spread-challenges-and-responses/2484476/The COP30 report finds climate change is expanding geographic risk for vectorborne and zoonotic infections,
- Monoclonal Antibodies in RSV Prevention: Potential Game-Changer for Infant Healthhttps://reachmd.com/news/monoclonal-antibodies-in-rsv-prevention-potential-game-changer-for-infant-health/2484475/A recent study found that nirsevimab reduced RSV-related hospitalizations by 79% overall, substantially lowering severe infant outcomes during the winter
- Optimal Exercise Therapy for Chronic Ankle Instability: Insights from a Systematic Review and Meta-Analysishttps://reachmd.com/news/optimal-exercise-therapy-for-chronic-ankle-instability-insights-from-a-systematic-review-and-meta-analysis/2484477/A recent systematic review and meta-analysis of randomized trials shows exercise therapy improves patient-oriented function in chronic ankle instability (CAI), making targete
- Current Insights into Managing Hypoxemic Emergencies in the EDhttps://reachmd.com/news/current-insights-into-managing-hypoxemic-emergencies-in-the-ed/2484458/An outbreak of EVALI in Bogotá produced rapid severe hypoxemia and ARDS in young adults — this article summarizes ED recognition and management, practical imaging approaches for COPD exacerbations, and key markers that distinguish neonatal hypoxemic conditions. In a